| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-12 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-11 |
| mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-11 |
| mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-08 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-07 |
| mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
| mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-06 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-06 |